Similarly, the addition of recombinant CXCL5 to papillary thyroid carcinoma cells downregulated epithelial cell markers and upregulated mesenchymal markers through activating β-catenin signaling [35]. This evidence concerns the gene CXCL5 and thyroid gland papillary carcinoma.